Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
5.51%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth5.51%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
5.0
38.40%
80%
—
-100.00%
20%
—
5 Years
Score5.0
Net Growth38.40%
Net Trend80%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Biocardia Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 145K to $ 0.00 and net income went from -$ 15M to -$ 8M. Revenue increased in 1 of those 5 years; net income in 4.
Across Biocardia Inc's full reported history, from 2008 to 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 5M to -$ 8M. Revenue increased in 63% of the years measured; net income in 50%.
Biocardia Inc currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.88 | — |
1 Year2025-08-12 | $ 1.74 | -49.43% |
5 Years2021-08-12 | $ 48.60 | -98.19% |
10 Years2016-08-12 | $ 226.80 | -99.61% |
20 Years2006-08-11 | $ 1.21K | -99.93% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 0.88 | $ 1.74 | $ 48.60 | $ 226.80 | $ 1.21K |
| Return | — | -49.43% | -98.19% | -99.61% | -99.93% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 7M | $ 951K |
| 2025 | $ 0.00 | -$ 8M | $ 2M |
| 2024 | $ 58K | -$ 7M | $ 2M |
| 2023 | $ 477K | -$ 11M | $ 1M |
| 2022 | $ 1M | -$ 11M | $ 7M |
| 2021 | $ 1M | -$ 12M | $ 12M |
| 2020 | $ 145K | -$ 15M | $ 21M |
| 2019 | $ 710K | -$ 14M | $ 5M |
| 2018 | $ 625K | -$ 13M | $ 5M |
| 2017 | $ 479K | -$ 12M | $ 12M |
| 2016 | $ 576K | -$ 10M | $ 21M |
| 2015 | $ 517K | $ 322K | $ 13M |
| 2014 | $ 427K | $ 234K | $ 13M |
| 2013 | $ 268K | $ 19K | $ 13M |
| 2012 | $ 62K | $ 305K | $ 13M |
| 2011 | $ 12K | $ 9M | $ 12M |
| 2010 | -$ 11M | $ 127K | |
| 2009 | $ 1M | -$ 5M | $ 4M |
| IPO2008 | $ 1M | -$ 5M | $ 3M |
Explore beyond BCDA
You're looking at Biocardia Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
